These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16323125)

  • 1. Influenza immunity: new insights from old studies.
    Kilbourne ED
    J Infect Dis; 2006 Jan; 193(1):7-8. PubMed ID: 16323125
    [No Abstract]   [Full Text] [Related]  

  • 2. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.
    Epstein SL
    J Infect Dis; 2006 Jan; 193(1):49-53. PubMed ID: 16323131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexisting antibodies against pandemic 2009 influenza A (H1N1) virus in Taiwan.
    Chang SC; Chang CM; Huang YC; Chiu CH; Shih SR; Lin TY
    Clin Infect Dis; 2010 Dec; 51(12):1465-7. PubMed ID: 21082879
    [No Abstract]   [Full Text] [Related]  

  • 4. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.
    Lindemann M; Witzke O; Lütkes P; Fiedler M; Kreuzfelder E; Philipp T; Roggendorf M; Grosse-Wilde H
    Clin Immunol; 2006 Sep; 120(3):342-8. PubMed ID: 16631409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.
    Zanvit P; Havlícková M; Tácner J; Novotná O; Jirkovská M; Cechová D; Julák J; Sterzl I; Prokesová L
    Immunol Lett; 2008 Jan; 115(2):144-52. PubMed ID: 18160106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological surveillance of 2009 H1N1 influenza in China.
    Yang P; Shi W; Tian L; Li S; Zhang L; Huang F; Wang Q
    Int J Infect Dis; 2011 Feb; 15(2):e151-2. PubMed ID: 21145771
    [No Abstract]   [Full Text] [Related]  

  • 7. 2009 H1N1 influenza virus seroepidemiology.
    Wiwanitkit V
    Iran J Immunol; 2010 Jun; 7(2):130; author reply 130-1. PubMed ID: 20574127
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
    Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza pandemics, immune cross-reactivity, and pandemic control strategies.
    Gioia C; Agrati C; Castilletti C; Capobianchi MR; Martini F
    J Infect Dis; 2008 Jul; 198(2):294-5; author reply 295-6. PubMed ID: 18593297
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza: accounting for prior immunity.
    McCaw JM; McVernon J; McBryde ES; Mathews JD
    Science; 2009 Aug; 325(5944):1071; author reply 1072-3. PubMed ID: 19713508
    [No Abstract]   [Full Text] [Related]  

  • 11. . . . And an editorial view.
    Child Health Alert; 2010 Feb; 28():1-2. PubMed ID: 20437618
    [No Abstract]   [Full Text] [Related]  

  • 12. An introduction to influenza: lessons from the past in epidemiology, prevention, and treatment.
    Belshe RB
    Manag Care; 2008 Oct; 17(10 Suppl 10):2-7. PubMed ID: 19025131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serological survey on antibodies to influenza A viruses subtype H1, H3, H5 and H9 of population in Shanghai].
    Lv XH; Jiang CY; Zhou YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):302. PubMed ID: 19642392
    [No Abstract]   [Full Text] [Related]  

  • 14. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
    Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
    J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination of children.
    Heikkinen T; Peltola V
    Lancet Infect Dis; 2009 Dec; 9(12):720-1. PubMed ID: 19879806
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with seropositivity of 2009 H1N1 influenza in Beijing, China.
    Liu W; Yang P; Duan W; Wang X; Zhang Y; Wang Q
    Clin Infect Dis; 2010 Jul; 51(2):251-2. PubMed ID: 20560736
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM; Tweed SA; De Serres G
    J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One step closer to universal influenza epitopes.
    Li OT; Poon LL
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cheaper approaches to flu divide researchers.
    Butler D
    Nature; 2007 Aug; 448(7157):976-7. PubMed ID: 17728727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.